Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-08-29

Clinical Trial Update: Modafinil and Naltrexone to Reduce Cocaine and Alcohol Dependence [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating modafinil and naltrexone to reduce cocaine and alcohol dependence, with completed status and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Modafinil (modafinil)
  • Naltrexone (Naltrexone)

Snippet

Sponsor: Kyle Kampman | Conditions: Alcohol-Related Disorders, Alcoholism | Phase 2 | Status: COMPLETED | Results posted: 2014-08-29